Our primary focus for decades has been to provide you with the best possible support and to improve our services to meet the needs of your cardiovascular patients. Recently, we have developed medications not only for patients who require anticoagulation but also for rare diseases like hypertrophic cardiomyopathy (HCM). That's why we offer a rich collection of materials to download and further information by clicking on the links below. Please don't hesitate to reach out to your BMS contact to learn more.

My Eliquis^® in a Box

Your Customized Documents for Eliquis^®

From now on, "My Eliquis^® in a Box" is available for downloads of your customized Eliquis^® information. Make your informed decisions about the use/application of Eliquis^®, as we want to simplify your access to high-quality and reliable information. With “My Eliquis^® in a Box,” you can quickly download the information you need.

Your immediate access:

Do you want to have the most important information readily available for yourself and your patients?

Discover here the materials available with which you can assemble your personal “Eliquis-Box.” “Make it your own.”

List of additional available documents:

Selected Materials for Professionals

Dosage Management:

Information for dosage management and stroke prevention in non-valvular atrial fibrillation (nvAF) and patient management.

Pocket guide

The Eliquis^® Pocket Guide is designed to support you in your daily practice and in managing your patients.

Ray W.A. et al. Folder

Folder with data from the independent real-world analysis.*

Materials to Support Your Patient Conversations

Emergency Pass

The emergency passport is intended to provide rescue services and medical professionals with important information about your health condition.

Brochure on Stroke Prevention in Atrial Fibrillation (AF)

Brochure for patients with atrial fibrillation who have been prescribed Eliquis^® (Apixaban) to prevent blood clots.

Brochure on Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)

This information brochure is aimed at patients who have been prescribed Eliquis^®

Brochure on Prevention of Blood Clots After Hip or Knee Replacement Surgery

Information brochure for patients who have been prescribed Eliquis^® (Apixaban) to prevent blood clots after hip or knee replacement surgery.

Eliquis^®in Patients with VTE

Information brochure for the treatment of patients with venous thromboembolism (VTE).

Specific, Selected Additional Information on DOACs (Direct Oral Anticoagulants)

ESC Guidelines

Guidelines for stroke prevention in atrial fibrillation - European Society of Cardiology (ESC) Guidelines 2020.

DOAC (Direct Oral Anticoagulants) Overview

Overview of the dosages and pharmacological properties of DOAC (Direct Oral Anticoagulants).

Documents on Service and Our Ordering Options

Order Form

Material order form for printed information and materials on Eliquis^®.

Get even more out with specific information topics:

The “immediate access” is very convenient, but do you need more specific information?

In this area, additional documents are available for you to select and use in your Eliquis-Box.

List of additional available documents:

Additional Available Documents

Folder on Risk Factors for Bleeding

This folder answers the following questions: Where do severe bleedings occur under DOAC (Direct Oral Anticoagulants) therapy. What are possible risk factors for gastrointestinal bleeding under DOAC therapy?

Folder on Atrial Fibrillation and Reduced Kidney Function

This folder contains information for patients with non-valvular atrial fibrillation (nvAF) with reduced kidney function.

Patient case PD Dr. med. Florim Cuculi

Therapeutic anticoagulation after PCI in an elderly patient with non-valvular atrial fibrillation (nvAF) and increased risk of bleeding.

Patient case Dr. Vladimir Rubimbura

Case Card: Patient with non-valvular atrial fibrillation (nvAF) and renal insufficiency: which anticoagulation after myocardial infarction and stent?

Adherence Folder

Information brochure on Eliquis^®. dosing frequency.

Brochure Which DOAC for Which of Your Patients

This information brochure contains the results of large independent real-world analyses (Ray W.A. et al. JAMA. 2021;326(23):2395-2404 & Dawwas G.K. et al. Ann Intern Med. 2022 Jan;175(1):20–28)

Make your own download document box

Printed Materials on Request

If you wish to have printed materials, we can assist you. Here you will find the instructions to order printed materials:

Patient Brochure Order Form

Download the available order form, and send your order to: eliquis-ch@bms.com

On request

The following risk minimizing materials from the Pharmacovigilance Department can be ordered from your Eliquis contact person, or by email at: eliquis-ch@bms.com

Guide for Physicians

(Risk minimizing material from the Pharmacovigilance Department. Available in German - French - Italian)

Plastic Box with 20 pcs. Guide for Physicians

(Risk minimizing material from the Pharmacovigilance Department. Available in German - French - Italian)

Do you have further needs?

Click here, in our "Media Library", available in German and French, there are more materials that can help you. Click here for the German "Media Library" Click here for the French "Media Library"

If you prefer a more personal approach and would like advice, please contact the sales representative responsible for your region to receive information tailored to you.

References available upon request

* Ray W.A. et al. Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation. JAMA. 2021;326(23):2395-2404.